Exact Mass: 319.006867
Exact Mass Matches: 319.006867
Found 137 metabolites which its exact mass value is equals to given mass value 319.006867,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
ONO-2235; ONO 2235; ONO2235; Sorbistat
2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide
Hernandonine
An oxoaporphine alkaloid isolated from Hernandia ovigera and Lindera chunii and has been shown exhibit inhibitory activity against HIV-1 integrase .
Cassameridine
An oxoaporphine alkaloid that is 7H-dibenzo[de,g]quinolin-7-one which is substituted by methylenedioxy grups at the 1,2 and 9,10 positions. Compared with liriodenine, which lacks the 9,10-methylenedioxy group, cassameridine displays only moderate antifungal activity.
Epalrestat
C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D004791 - Enzyme Inhibitors
4-(4,5-dichloro-6-oxopyridazin-1-yl)benzenesulfonamide
(R)-2-(4-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
Cetophenicol
C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
3-bromo-4-[(4-methylphenyl)methylamino]benzoic acid
(S)-2-(4-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
1-(PHENYLSULFONYL)-1H-INDOLE-2-CARBONYL CHLORIDE
C15H10ClNO3S (319.00699000000003)
2-[(3-BROMOANILINO)CARBONYL]-BENZOIC ACID
C14H10BrNO3 (318.98440100000005)
2-[(4-BROMOANILINO)CARBONYL]-BENZOIC ACID
C14H10BrNO3 (318.98440100000005)
1-(3-Bromo-5-methylpyridin-2-yl)-4-ethylpiperazine hydrochloride
2-methyl-3-sulfobutyl-5-chlorobenzothiazolium, inner salt
2-(2-(4-BROMO-1H-PYRAZOL-1-YL)ETHYL)ISOINDOLINE-1,3-DIONE
6,7-Difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
C16H8F3NO3 (319.04562540000006)
2-[(4-bromobenzoyl)amino]benzoic acid
C14H10BrNO3 (318.98440100000005)
2-amino-2-(3,4-dichlorophenyl)-3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoic acid
2,6-dimethyl-3-ethylbenzothiazolium iodide
C11H14INS (318.98916740000004)
2-[(2-bromobenzoyl)amino]benzoic acid
C14H10BrNO3 (318.98440100000005)
Bupropion hydrobromide
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
4-(4-chloro-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one
2-[[(2-BROMOPHENYL)AMINO]CARBONYL]-BENZOIC ACID
C14H10BrNO3 (318.98440100000005)
1-[(4-Bromophenyl)sulfonyl]-4-piperidinol
C11H14BrNO3S (318.98777140000004)
Astat
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives C254 - Anti-Infective Agent > C514 - Antifungal Agent
1-[(5-Bromo-2-methoxyphenyl)sulfonyl]pyrrolidine
C11H14BrNO3S (318.98777140000004)
3-amino-6-phenyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carbonitrile
C15H8F3N3S (319.03910040000005)
5-BROMO-3-(2-PYRIDIN-2-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE
C13H14BrN5 (319.04325040000003)
5-BROMO-3-(2-PYRIDIN-3-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE
C13H14BrN5 (319.04325040000003)
4-(4-Bromophenyl)piperidine-4-carboxylic acid hydrochloride
C12H15BrClNO2 (318.99746200000004)
4-((4-Bromo-3-methylphenyl)sulfonyl)morpholine
C11H14BrNO3S (318.98777140000004)
7-(1,3-Benzothiazol-2-yl)-6-hydroxy-4-oxo-1,4-dihydro-3-quinoline carbonitrile
5-[3,5-Bis(trifluoromethyl)phenyl]-3-pyridinecarbaldehyde
C14H7F6NO (319.04318040000004)
ETHYL1-(4-BROMOPHENYL)-5-CYANO-1H-PYRAZOLE-4-CARBOXYLATE
(S)-2-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
N-(4-Chlorobenzoyloxy)-4-nitrobenzimidamide
4-[4-(bromomethyl)phenyl]sulfonylmorpholine
C11H14BrNO3S (318.98777140000004)
4-Chloro-6-(trifluoromethoxy)quinoline-3-carboxylic acid ethyl ester
C13H9ClF3NO3 (319.02230299999997)
1-(3-Bromophenyl)-2-[(2-methyl-2-propanyl)amino]-1-propanone hydr ochloride (1:1)
1-(3-bromo-4-methylphenylsulfonyl)morpholine
C11H14BrNO3S (318.98777140000004)
4-((2-(Bromomethyl)phenyl)sulfonyl)morpholine
C11H14BrNO3S (318.98777140000004)
(R)-2-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
4-(6-Bromo-4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine
(2S,4R)-4-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
(2S,4R)-4-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
(2S,4R)-4-(4-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
(S)-2-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
(R)-2-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
3-(5,6-dichloro-1-methylindol-2-yl)benzoic acid
C16H11Cl2NO2 (319.01668060000003)
4-(2-(2-BROMO-5-CHLOROPHENOXY)ETHYL)MORPHOLINE
C12H15BrClNO2 (318.99746200000004)
1-[(3-Bromophenyl)sulfonyl]-4-piperidinol
C11H14BrNO3S (318.98777140000004)
1-(benzenesulfonyl)indole-3-carbonyl chloride
C15H10ClNO3S (319.00699000000003)
n-(2-(4-bromophenoxy)ethyl)piperidine hydrochloride
4-(3-Chloro-2-fluoroanilino)-6-hydroxy-7- methoxyquinazoline
4-(chloromethyl)-2-(4-ethoxy-3-methoxyphenyl)-1,3-thiazole hydrochloride
2-Propanesulfinamide, N-[1-(5-bromo-2-fluorophenyl)ethylidene]-2-methyl-, [N(E),S(S)]-
C12H15BrFNOS (319.00416920000004)
FAAH-IN-2
FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent FAAH(fatty acid amide hydrolase) inhibitor extracted from Patent WO/2008/100977A2.
2-METHYL-3-PROPYLBENZOTHIAZOLIUM IODIDE
C11H14INS (318.98916740000004)
2-1H-indol-3-ylisothiourea, monohydroiodide
C9H10IN3S (318.96401700000007)
1-[(3-Bromo-4-methoxyphenyl)sulfonyl]pyrrolidine
C11H14BrNO3S (318.98777140000004)
6-Chloro-2-(4-chlorophenyl)imidazo[1,2-α]pyridine-3-acetamide
C15H11Cl2N3O (319.02791360000003)
4-Pyrimidinamine, 5-bromo-N-cyclopentyl-2-(Methylsulfonyl)-
C10H14BrN3O2S (318.99900440000005)
1-(4-Nitrophenyl)-5-(trifluoromethyl)pyrazole-4-carbonyl chloride
C11H5ClF3N3O3 (318.99715260000005)
2-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid
4-fluoro-N-(4-fluoro-1,3-benzothiazol-2-yl)-1,3-benzothiazol-2-amine
N-(4-methyl-2-thiazolyl)-3-(2-oxo-1,3-benzothiazol-3-yl)propanamide
4-(5-Bromo-2-thiophenyl)-6-methyl-2-(1-pyrrolyl)pyrimidine
C13H10BrN3S (318.97787600000004)
3,4-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate
Benzene, 1,2,3,4,5-pentafluoro-6-((4-nitrophenoxy)methyl)-
C13H6F5NO3 (319.02678260000005)
3,4,8,9,10-Pentahydroxy-6-oxobenzo[c]chromene-1-carboxylate
(2R,3R)-3,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-5-olate
N-[4-[[acetamido(sulfanylidene)methyl]amino]phenyl]-2-thiophenecarboxamide
6-Ethoxy-2-[(4-fluorophenyl)methylthio]-1,3-benzothiazole
N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2,2,2-trichloroacetamide
[3-(4-Chlorophenyl)-5-(methylthio)-1,2,4-triazol-1-yl]-(2-furanyl)methanone
C14H10ClN3O2S (319.01822300000003)
(4-Bromo-2,5-dimethyl-3-pyrazolyl)-(2,3-dihydroindol-1-yl)methanone
C14H14BrN3O (319.03201740000003)
N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide
C11H14ClN3O4S (319.03935140000004)
(E)-3-(5-bromofuran-2-yl)-N-[(4-methylphenyl)methyl]prop-2-enamide
1-[[2-(3,4-Dichlorophenyl)acetyl]amino]-3-propylthiourea
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-N-sulfooxymethanimidothioate
(2S)-2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide
N-(2,4-Dichloro-5-(2-hydroxyethoxy)phenoxycarbonyl)tetrahydropyrrole
4-(3,5-Dichloro-4-hydroxyphenylimino)tetralin-1-one
C16H11Cl2NO2 (319.01668060000003)